Evidence map›Paper›PMID 38553254›Full record

ArticleGenes to cells : devoted to molecular & cellular mechanisms2024

"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia.

Rieko Ohki, Koji Itahana, Tomoo Iwakuma

Open access · bronzeAbstract readConference Proceedings
In one paragraph

Article in Genes to cells : devoted to molecular & cellular mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Rieko OhkiLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7775-6653
Koji ItahanaCancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.ORCID https://orcid.org/0000-0002-7241-2894
Tomoo IwakumaDepartment of Pediatrics, Children's Mercy Research Institute, Kansas City, Missouri, USA.ORCID https://orcid.org/0000-0001-7249-7958
Duke-NUS Medical School · SGMercy Research · USNational Cancer Research Institute · GB

Funding

The 10th International MDM2 WorkshopR13CA281369 · NCI · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI IWAKUMA, TOMOO · 2023 to 2023
$15k
Children's Mercy Research InstituteChugai Foundation for Innovative Drug Discovery ScienceChugai Pharmaceutical Co. LtdDuke-NUS Medical School, SingaporeInternational Medical Research FoundationMolecular Biology Society of JapanNaito FoundationNCI NIH HHS R13 CA281369NCI NIH HHS R13CA281369-01PMV PharmaThe Novartis FoundationThe Uehara Memorial FoundationUniversity of Kansas Cancer Center
6 · The paper itself

Abstract

The 10th International MDM2 Workshop was held at the National Cancer Center Research Institute (NCCRI) in Tokyo, Japan, from October 15 to 18, 2023. It attracted 166 participants from 12 countries. The meeting featured 52 talks and 41 poster presentations. In the first special session, six invited speakers gave educational and outstanding talks on breakthroughs in MDM2 research. Three keynote speakers presented emerging p53-independent functions of MDM2/MDM4, functional association of MDM2/p53 with cancer immunity, and drug discovery targeting the MDM2/MDM4-p53 pathway. Additionally, 19 invited speakers introduced their new findings. Twenty-one presenters, many of whom were young investigators, postdocs, and students, were selected from submitted abstracts and reported their exciting and unpublished results. For poster presenters, outstanding poster awards were given to the best presenters. There were many inspiring questions and discussions throughout the meeting. Social events like a welcome party, a workshop dinner, and an optional tour enabled further scientific interactions among the participants. The meeting successfully provided an exciting platform for scientific exchange. The experience gained from organizing this meeting will be handed over to the next organizers of the 11th International MDM2 Workshop.

Indexed as

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53AnimalsAsiaHumansNeoplasmsMDM2 protein, humanProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53cancerInternational MDM2 WorkshopMDM2MDMXoncogenep53tumor suppressor

Identifiers

PMID38553254
PMCPMC11164626
OpenAlexW4393344339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.